We are Not Meeting the Needs of Pharmacoeconomic Models of Nonalcoholic Steatohepatitis, But We Can Elliot B. TapperJagpreet Chhatwal Commentary 21 February 2020 Pages: 427 - 429
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Xavier G. L. V. PouwelsSvenja PetersohnManuela A. Joore Review Article Open access 08 November 2019 Pages: 431 - 441
Valuing Healthcare Goods and Services: A Systematic Review and Meta-Analysis on the WTA-WTP Disparity Adriënne H. RotteveelMattijs S. LambooijG. Ardine de Wit Systematic Review Open access 25 February 2020 Pages: 443 - 458
Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs Salah GhabriLaurent LamHans-Martin Spath Systematic Review 13 February 2020 Pages: 459 - 471
Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic Review Matteo RuggeriCarlo DragoCostanza Santori Systematic Review 28 February 2020 Pages: 473 - 484
Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements Pierre JohansenDaniel HowardKristine Buchholtz Systematic Review Open access 10 January 2020 Pages: 485 - 497
Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling Kim DalzielMax CatchpoolOliver Rivero-Arias Original Research Article Open access 24 January 2020 Pages: 499 - 513
Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach Lih-Wen MauJaime M. PreusslerDavid J. Vanness Original Research Article 04 March 2020 Pages: 515 - 526
